Navigation Links
Silicon Beach-Based Nonprofit Startup Cure Glioblastoma Launches Laboratory Operations and Appoints Drs. John Boockvar and Lisa Haile as Senior Fellows

Cure Glioblastoma, a registered 501(c)(3) nonprofit research organization focused on building awareness and solutions for glioblastoma—the most common and aggressive adult brain cancer—announced today the appointments of its first Senior Fellows: John Boockvar, MD and Lisa Haile, JD, PhD. Senior Fellows are charged with supporting the organization’s initiatives and overall vision.

"Senior Fellows are more than advisors; they are integral members of the organization with a deep connection to the disease,” said, Cofounder and President of Cure Glioblastoma, W. Shawn Carbonell, MD, PhD. “Cure Glioblastoma is unusual in that we are essentially a nonprofit biotech startup leading our own cutting-edge immunotherapy research programs through our newly launched laboratory operations at BioLabs LA at The Lundquist Institute. The involvement of the Senior Fellows is critical during these difficult times as we are actively seeking to grow the organization and scale our impact for the immediate benefit of patients.”

John Boockvar, MD, is Vice Chair of Lenox Hill Hospital Neurosurgery in New York City. He is a neurosurgeon-scientist and runs the Laboratory for Brain Tumor Biology at the Feinstein Institute for Medical Research. He is also a principal cast member in the new hit Netflix docuseries “Lenox Hill” which prominently features his clinical research and the journey of several of his glioblastoma patients. Dr. Boockvar stated, “It is truly an honor to be a founding Senior Fellow of Cure Glioblastoma. Defeating this complex disease will require synergy that comes from the marriage of knowledge, clinical and research tools, biotechnology, experience, a great team, and most importantly, a will to do things differently.”

“I’ve worked with Dr. Carbonell for nearly a decade in the industry,” said Lisa Haile, JD, PhD a Partner at DLA Piper LLP in San Diego, California with nearly 30 years of experience representing biopharma companies in intellectual property strategy and protection. Dr. Haile was the former co-chair of the Global Life Sciences Practice at DLA Piper for 15 years. She continued, “It is my absolute pleasure to join the fight and serve as a Senior Fellow in this unique new effort, particularly after having recently lost a close friend and colleague to this devastating disease.”

In addition to their ongoing internal research and development efforts, Cure Glioblastoma is working on several new initiatives including a curated clinical trials database, Junior Fellowships for trainees, a black student brain cancer research scholarship, a biotech startup fund, and promoting brain cancer awareness through its patient, influencer, and celebrity networks.

Dr. Carbonell concluded, “We are grateful for all the support during this first year of operations including from patients and their families and friends, donors, our loyal social media following, and our corporate sponsors and providers including Barrister Executive Suites and BioLabs LA, respectively."

Cure Glioblastoma Inc. is a registered 501(c)(3) public charity operating through an entrepreneurial lean startup model to defeat brain cancer. It was cofounded in Venice, California in 2019 by W. Shawn Carbonell, MD, PhD—inventor of novel glioblastoma drug candidate OS2966—and Barbie Blank—model, influencer, and former WWE Divas Wrestling Champion who recently lost her father to glioblastoma. Luzanne Otte, JD is a founding member of the Board of Directors joining in memory of her aunt, Jenny Kanoff Otte, who passed away from glioblastoma.

To learn more, please visit

Read the full story at

Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved

Related biology news :

1. CTL Medical to Become World’s Only Provider of Silicon Nitride Spine Products
2. Artificial membranes on silicon
3. Fingerprint Readers with DigitalPersona Silicon-based Sensors Certified for China Resident Identity Card
4. Johns Hopkins And Belgian research center to expand health care applications for silicon nanotech
5. Silicon-based Fingerprint Sensors - Global Strategic Business Report
6. Healthcare Startup Offers Remote Cardiac Monitoring During COVID-19 Pandemic
7. PM360 Names Pharmafusion One of the Most Innovative Startups of 2019
8. Introducing Natalist, the Women’s Health Startup Making Beautiful, Science-Backed Conception Essentials
9. Zer0 to 5ive Turns 20; Celebrates with Launch of New Startup Package
10. Student Startup Teams Compete for $75,000 at WSU’s 17th Annual Business Plan Competition
11. Smart Health Innovation Lab Partners with Redox to Help Innovative Healthcare Startups Accelerate Time to Integration
Post Your Comments:
(Date:6/5/2020)... ... 04, 2020 , ... “Although we are disappointed to have to make this ... and the public. We remain committed to creating a global platform to showcase ... Julie Sutcliffe, President of WMIS. , The abstract deadline for the ...
(Date:6/2/2020)... ... June 02, 2020 , ... ... barcode and RFID labeling software developer and solutions provider, today reported that ... improved labeling accuracy and compliance by 100%, resulting in greater efficiency for ...
(Date:5/28/2020)... ... May 27, 2020 , ... CrucialTrak, a global designer and ... Jersey-based Critical Environments Group (CEG) to market and sell its complete line of ... and IT environment infrastructure optimization solutions . , Brett Mason, CrucialTrak’s Director ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... After research model surgery and catheter ... great surgery is only the beginning of a successful study, while protecting and accessing ... Brad Gien, Global Head of Surgery from Envigo in a live ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Technology (MIT) has expanded the company’s exclusive license to include clinical applications ... point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast ...
(Date:7/1/2020)... N.C. (PRWEB) , ... June 29, 2020 , ... ... reported year to date growth of 40% in 2020, despite many obstacles created ... technology, MedShift aims to increase revenue for its partnered medical practices and medical ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... for treating cancer, today announced the company has entered a license agreement with ... agreement provides Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a ...
Breaking Biology Technology: